Pharmacokinetics and Pharmacodynamics — MCQs

The pharmacokinetic properties of a new antihistamine are being studied in normal volunteers during phase I clinical trials. The clearance and half-life of the drug are determined to be 4.0 L/hour and 10 hours, respectively. Which of the following values is the approximate volume of distribution for this drug?

Q80Easy

Zero order kinetics is followed by all of the following drugs EXCEPT:

Pharmacokinetics and Pharmacodynamics Indian Medical PG Practice Questions and MCQs

Question 71: Which of the following drugs is not metabolized by the liver?

A. Flunitrazepam
B. Diazepam
C. Oxazepam (Correct Answer)
D. Nitrazepam

Explanation: **Explanation:** The metabolism of Benzodiazepines (BZDs) primarily occurs via two phases in the liver: **Phase I (Oxidation)** by Cytochrome P450 enzymes and **Phase II (Conjugation)** with glucuronic acid. **Why Oxazepam is the correct answer:** Most BZDs undergo Phase I oxidation to form active metabolites, which significantly prolongs their duration of action. However, a specific group of BZDs—**Oxazepam, Temazepam, and Lorazepam (mnemonic: OTL)**—bypass Phase I oxidation entirely. They undergo direct **Phase II glucuronidation** to form inactive, water-soluble metabolites that are excreted by the kidneys. Because they do not rely on the CYP450 system, they are the drugs of choice in patients with **liver failure** or the **elderly**, where oxidative capacity is diminished. **Analysis of Incorrect Options:** * **Diazepam:** A long-acting BZD that undergoes extensive Phase I metabolism to form active metabolites like desmethyldiazepam (nordiazepam), giving it a very long half-life. * **Flunitrazepam & Nitrazepam:** These are nitro-benzodiazepines. They undergo Phase I reduction and acetylation in the liver before excretion. **NEET-PG High-Yield Pearls:** 1. **OTL (Oxazepam, Temazepam, Lorazepam):** "Outside The Liver" (mnemonic for bypassing Phase I). Safe in cirrhosis and elderly patients. 2. **Active Metabolites:** Diazepam and Chlordiazepoxide have the longest-acting active metabolites. 3. **Enzyme Inhibition:** Drugs like Cimetidine or Erythromycin inhibit CYP450 and can increase the toxicity of Diazepam, but they do **not** affect the clearance of Oxazepam or Lorazepam.

Question 72: Which of the following characteristics best describes phenytoin pharmacokinetics?

A. High first pass metabolism
B. Nonsaturation kinetics of metabolism
C. Capacity limited metabolism that saturates at higher therapeutic concentration ranges (Correct Answer)
D. Extrahepatic metabolism

Explanation: ### Explanation **Phenytoin** follows a unique pharmacokinetic pattern known as **Zero-order kinetics** (also called non-linear, capacity-limited, or Michaelis-Menten kinetics) at higher therapeutic concentrations. **1. Why Option C is Correct:** Most drugs follow first-order kinetics, where a constant *fraction* of the drug is eliminated per unit time. However, the hepatic enzymes (CYP2C9 and CYP2C19) responsible for metabolizing phenytoin have a limited capacity. Once these enzymes become saturated—which typically occurs within the upper therapeutic range (10–20 µg/mL)—the body can only metabolize a constant *amount* of the drug regardless of the plasma concentration. Consequently, even a small dose increase can lead to a disproportionately large rise in plasma levels, increasing the risk of toxicity. **2. Why Other Options are Incorrect:** * **Option A:** Phenytoin has high oral bioavailability (~90%) and does **not** undergo significant first-pass metabolism. * **Option B:** Phenytoin exhibits **saturation kinetics**. "Nonsaturation" describes first-order kinetics, where clearance remains constant regardless of dose. * **Option C:** Phenytoin is primarily metabolized in the **liver** via parahydroxylation; extrahepatic metabolism is negligible. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "V-W-P" Rule:** Remember the drugs following Zero-order kinetics using the mnemonic **"V-W-P"** (**V**erapamil/Valproate (toxic doses), **W**arfarin/Whiskey (Alcohol), **P**henytoin/Theophylline/Salicylates). * **Therapeutic Window:** 10–20 µg/mL. * **Toxicity Signs:** Nystagmus (earliest sign), ataxia, and diplopia. * **Teratogenicity:** Fetal Hydantoin Syndrome (cleft lip/palate, digital hypoplasia). * **Side Effects:** Gingival hyperplasia, hirsutism, and osteomalacia (due to Vitamin D interference).

Question 73: Which of the following is a pro-drug?

A. Clonidine
B. Enalapril (Correct Answer)
C. Streptomycin
D. Morphine

Explanation: **Explanation:** **Enalapril** is the correct answer because it is a **prodrug**, an inactive compound that must undergo metabolic conversion (usually in the liver) to become pharmacologically active. Enalapril is converted by hepatic esterases into its active form, **Enalaprilat**, which then acts as an ACE inhibitor. Most ACE inhibitors are prodrugs (e.g., Ramipril, Perindopril) to improve oral bioavailability, with two notable exceptions: **Lisinopril and Captopril**, which are active as administered. **Analysis of Incorrect Options:** * **Clonidine:** An alpha-2 adrenergic agonist used in hypertension. It is active in its parent form and does not require metabolic activation. * **Streptomycin:** An aminoglycoside antibiotic that acts directly by binding to the 30S ribosomal subunit. It is not a prodrug. * **Morphine:** A potent opioid analgesic that is active itself. While it has active metabolites (e.g., Morphine-6-glucuronide), the parent drug is pharmacologically active upon administration. **High-Yield Clinical Pearls for NEET-PG:** * **ACE Inhibitor Exceptions:** Remember the mnemonic **"CL"** (Captopril and Lisinopril) for ACE inhibitors that are **NOT** prodrugs. * **Common Prodrugs:** High-yield examples include Levodopa (to Dopamine), Cyclophosphamide (to Phosphoramide mustard), Clopidogrel, and Valacyclovir. * **Advantages of Prodrugs:** They are designed to improve absorption (bioavailability), decrease toxicity, or prolong the duration of action. * **Active Metabolites:** Do not confuse prodrugs with drugs that have active metabolites (e.g., Diazepam to Oxazepam). A prodrug *must* be inactive initially.

Question 74: Gentamicin has a half-life of 2-3 hours in plasma, but it accumulates in the kidney, prolonging its half-life to 53 hours. What is this prolonged half-life called?

A. Secondary half-life
B. Terminal half-life (Correct Answer)
C. Zero order half-life
D. First order half-life

Explanation: ### Explanation **Correct Option: B. Terminal half-life** **Underlying Concept:** Most drugs follow a **multi-compartment model** [1]. After administration, the drug first undergoes a rapid distribution phase (alpha phase) where plasma levels drop quickly as the drug moves into tissues. This is followed by an elimination phase (beta phase). The **terminal half-life** refers to the half-life of the drug during the final elimination phase, representing the slow release of the drug from deep tissue compartments (like the renal cortex for Gentamicin) back into the plasma. In the case of Aminoglycosides like Gentamicin, while the plasma half-life is short (2–3 hours), the drug binds tightly to tissue proteins in the kidneys and inner ear, leading to a much longer terminal half-life (50–100 hours). **Why Incorrect Options are Wrong:** * **A. Secondary half-life:** This is not a standard pharmacokinetic term used to describe tissue accumulation or elimination phases. * **C. Zero-order half-life:** In zero-order kinetics, a constant *amount* of drug is eliminated per unit time, meaning the half-life is not constant but decreases as the plasma concentration falls (e.g., Alcohol, Phenytoin at high doses). * **D. First-order half-life:** This refers to the constant time required to reduce the plasma concentration by 50%. While Gentamicin follows first-order kinetics [1], the specific term for the prolonged phase due to tissue sequestration is the "terminal" half-life. **NEET-PG High-Yield Pearls:** * **Gentamicin Toxicity:** The long terminal half-life in the renal cortex and endolymph explains why **nephrotoxicity** and **ototoxicity** can occur even after the drug has been discontinued. * **Post-Antibiotic Effect (PAE):** Aminoglycosides exhibit a significant PAE, allowing for **once-daily dosing** despite a short plasma half-life [1]. * **Elimination:** Aminoglycosides are excreted almost entirely by glomerular filtration; dosage must be adjusted in renal failure.

Question 75: If the clearance of a drug equals its renal plasma flow, what does it imply about the drug's handling by the kidneys?

A. The drug is actively reabsorbed in the renal tubules.
B. The drug is actively secreted into the renal tubules. (Correct Answer)
C. The drug undergoes neither significant secretion nor reabsorption in the renal tubules.
D. None of the above.

Explanation: The concept of **Renal Clearance ($CL_r$)** is a measure of the volume of plasma cleared of a drug per unit of time [3]. To understand how a drug is handled by the kidney, we compare its clearance to the **Glomerular Filtration Rate (GFR)** and **Renal Plasma Flow (RPF)**. 1. **Why Option B is Correct:** Normal GFR is approximately **125 mL/min**, while Renal Plasma Flow (RPF) is approximately **650 mL/min**. If a drug's clearance equals the RPF, it means that *all* the plasma passing through the kidney is being stripped of the drug in a single pass [2]. Since only 20% of plasma is filtered at the glomerulus, the remaining 80% must be cleared via **active tubular secretion** in the proximal tubules to reach a clearance value equal to the RPF [1]. 2. **Why Other Options are Incorrect:** * **Option A:** If a drug is actively reabsorbed (like glucose or certain electrolytes), its clearance will be significantly **lower than the GFR** ($<125$ mL/min) [1]. * **Option C:** If a drug undergoes only filtration with no secretion or reabsorption (like **Inulin**), its clearance will **equal the GFR** (~125 mL/min) [3]. **High-Yield NEET-PG Pearls:** * **Inulin Clearance:** The gold standard for measuring GFR ($CL = GFR$) [3]. * **Creatinine Clearance:** Slightly overestimates GFR because it undergoes a small amount of tubular secretion. * **Para-aminohippuric acid (PAH):** The classic example of a drug where clearance equals RPF because it is both filtered and completely secreted [2]. * **Formula:** $Excretion = (Filtration + Secretion) - Reabsorption$. If Clearance > GFR, secretion is occurring [1].

Question 76: Which of the following best defines bioavailability?

A. The volume of plasma completely cleared of a specific compound per unit time, serving as a measure of kidney function.
B. The proportion of an administered drug that reaches the systemic circulation unchanged. (Correct Answer)
C. Both A and B.
D. Neither A nor B.

Explanation: **Bioavailability (F)** is defined as the fraction or percentage of an administered dose of a drug that reaches the **systemic circulation in an unchanged (active) form** [1]. 1. **Why Option B is Correct:** When a drug is given intravenously (IV), its bioavailability is 100% ($F=1$). However, when given orally, the drug must be absorbed across the gut wall and pass through the liver via the portal vein. During this process, it may be metabolized before reaching the heart and systemic arteries—a phenomenon known as the **First-Pass Effect** [1]. Therefore, bioavailability is the measure of how much drug actually survives this "first pass" to become available at the site of action. 2. **Why Other Options are Incorrect:** * **Option A** describes **Clearance (CL)**, specifically renal clearance. Clearance refers to the efficiency of drug elimination from the body, not the entry of the drug into the circulation. * **Option C and D** are incorrect because only the definition of bioavailability is provided in Option B. **High-Yield NEET-PG Pearls:** * **Calculation:** $F = \frac{\text{AUC (oral)}}{\text{AUC (IV)}} \times 100$. (AUC = Area Under the Curve) [1]. * **Bioequivalence:** Two pharmaceutical products are bioequivalent if their bioavailability (rate and extent of absorption) does not show a significant difference when administered at the same dose. * **Factors reducing bioavailability:** Low lipid solubility, high first-pass metabolism (e.g., Nitroglycerin, Propranolol), and chemical instability in gastric pH (e.g., Penicillin G) [2].

Question 77: Time-dependent killing and prolonged post-antibiotic effect are characteristic of which class of antibiotics?

A. Fluoroquinolones
B. Beta-lactams (Correct Answer)
C. Clindamycin
D. Erythromycin

Explanation: ### Explanation **Correct Answer: B. Beta-lactams** **1. Why Beta-lactams are correct:** Antibiotics are classified based on their killing kinetics into two main patterns: **Time-dependent** and **Concentration-dependent**. * **Time-dependent killing:** The efficacy depends on the duration the serum drug concentration remains above the Minimum Inhibitory Concentration (MIC) of the pathogen ($T > MIC$). [3] * **Post-Antibiotic Effect (PAE):** This refers to the persistent suppression of bacterial growth even after the drug concentration falls below the MIC [2]. While Beta-lactams typically have a short PAE against Gram-negative bacteria, they exhibit a **prolonged PAE against Gram-positive cocci** (like Staphylococci) [1]. Therefore, Beta-lactams are the classic example of time-dependent killers with significant PAE in specific clinical contexts. **2. Why other options are incorrect:** * **A. Fluoroquinolones:** These exhibit **Concentration-dependent killing**. Their efficacy is determined by the Peak concentration ($C_{max}/MIC$) or the Area Under the Curve ($AUC/MIC$). They also possess a significant PAE against both Gram-positive and Gram-negative organisms [2]. * **C & D. Clindamycin and Erythromycin:** These are bacteriostatic protein synthesis inhibitors (Lincosamides and Macrolides). While they are time-dependent, they are generally not the primary focus for "killing" kinetics in the same way bactericidal agents like Beta-lactams are categorized in high-yield exams. **3. NEET-PG High-Yield Pearls:** * **Concentration-dependent killers:** Aminoglycosides, Fluoroquinolones, Daptomycin, and Metronidazole. (Mnemonic: **"A-F-D-M"**) [2] * **Time-dependent killers:** Beta-lactams (Penicillins, Cephalosporins, Carbapenems), Vancomycin, and Linezolid [1]. * **Clinical Application:** For Beta-lactams, dosing frequency or continuous infusions are more important than high bolus doses to maintain $T > MIC$. For Aminoglycosides, "Once-daily dosing" is preferred to maximize the $C_{max}$ and utilize the prolonged PAE while minimizing toxicity [2].

Question 78: Which of the following is NOT an example of nonlinear kinetics?

A. Metabolism of phenytoin
B. Biliary secretion of bromosulfthalein (BSP)
C. Glomerular filtration of naproxen
D. Metabolism of diazepam (Correct Answer)

Explanation: ### Explanation **Core Concept: Linear vs. Nonlinear Kinetics** Most drugs follow **Linear (First-order) kinetics**, where the rate of elimination is directly proportional to the plasma concentration (a constant fraction of drug is eliminated per unit time). **Nonlinear (Zero-order) kinetics** occurs when the elimination processes (enzymes or transporters) become saturated. In this state, a constant *amount* of drug is eliminated regardless of concentration. **Why Option D is Correct:** * **Metabolism of Diazepam:** Diazepam follows **First-order kinetics** at all therapeutic doses. Its rate of metabolism increases linearly with its plasma concentration, and it has a constant half-life ($t_{1/2}$). Therefore, it does *not* exhibit nonlinear kinetics. **Why the Other Options are Incorrect:** * **A. Metabolism of Phenytoin:** This is the classic example of **Michaelis-Menten kinetics**. At low doses, it is first-order, but the hepatic enzymes (CYP2C9) saturate easily at therapeutic levels, shifting it to zero-order (nonlinear) kinetics. * **B. Biliary secretion of BSP:** The transport mechanism for secreting Bromosulfthalein into the bile is a carrier-mediated process with a limited capacity ($T_{max}$). Once saturated, it follows nonlinear kinetics. * **C. Glomerular filtration of Naproxen:** While glomerular filtration is usually linear, Naproxen exhibits nonlinearity because it is highly protein-bound. At high doses, albumin binding sites become saturated, leading to a disproportionate increase in the "free fraction" of the drug available for filtration. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Zero-order (Nonlinear) drugs:** "**WATT P**an" — **W**arfarin, **A**lcohol/Asprin, **T**heophylline, **T**olbutamide, **P**henytoin. * **Key Feature:** In nonlinear kinetics, the $t_{1/2}$ is not constant; it increases as the dose increases. * **Saturation Kinetics:** Also known as Capacity-limited or Michaelis-Menten kinetics. Small dose increases can lead to toxic plasma levels.

Question 79: The pharmacokinetic properties of a new antihistamine are being studied in normal volunteers during phase I clinical trials. The clearance and half-life of the drug are determined to be 4.0 L/hour and 10 hours, respectively. Which of the following values is the approximate volume of distribution for this drug?

A. 0.06 L
B. 14 L
C. 45 L
D. 60 L (Correct Answer)

Explanation: ### Explanation **1. Why the Correct Answer is Right** The volume of distribution ($V_d$) is a theoretical volume that relates the amount of drug in the body to its concentration in the plasma. To solve this, we use the fundamental pharmacokinetic relationship between **Clearance ($CL$)**, **Half-life ($t_{1/2}$)**, and **Volume of Distribution ($V_d$)**: $$t_{1/2} = \frac{0.693 \times V_d}{CL}$$ Rearranging the formula to solve for $V_d$: $$V_d = \frac{t_{1/2} \times CL}{0.693}$$ **Calculation:** * $CL = 4.0 \text{ L/hr}$ * $t_{1/2} = 10 \text{ hours}$ * $V_d = \frac{10 \times 4.0}{0.693} \approx \frac{40}{0.7} \approx 57.14 \text{ L}$ The value **60 L** (Option D) is the closest approximation. **2. Why the Incorrect Options are Wrong** * **Option A (0.06 L):** This value is physiologically impossible for an adult and likely results from a decimal error in calculation. * **Option B (14 L):** This represents the extracellular fluid volume. A drug with this $V_d$ would be restricted to plasma and interstitial fluid. * **Option C (45 L):** This represents total body water (TBW). While closer, it does not match the mathematical result derived from the provided clearance and half-life. **3. Clinical Pearls & High-Yield Facts for NEET-PG** * **$V_d$ Interpretation:** If $V_d$ is low (approx. 3–5 L), the drug is confined to the vascular compartment (e.g., Warfarin). If $V_d$ is high (>42 L), the drug is sequestered in tissues (e.g., Digoxin, Chloroquine). * **Loading Dose:** $V_d$ is the primary determinant of the **Loading Dose** ($LD = V_d \times C_{ss}$). * **Clearance:** $CL$ is the primary determinant of the **Maintenance Dose**. * **Half-life:** It takes approximately **4 to 5 half-lives** to reach steady-state concentration ($C_{ss}$) and the same amount of time to eliminate the drug from the body after stopping.

Question 80: Zero order kinetics is followed by all of the following drugs EXCEPT:

A. Phenytoin
B. Barbiturates (Correct Answer)
C. Alcohol
D. Theophylline

Explanation: ### Explanation The core concept here is the difference between **First-order** and **Zero-order kinetics**. **1. Why Barbiturates is the Correct Answer:** Most drugs follow **First-order kinetics**, where a constant *fraction* of the drug is eliminated per unit time (rate depends on plasma concentration). **Barbiturates** (at therapeutic doses) follow first-order kinetics. Therefore, they are the "exception" in this list of drugs known for following zero-order kinetics. **2. Understanding Zero-Order Kinetics (The Incorrect Options):** In **Zero-order kinetics**, a constant *amount* of drug is eliminated per unit time, regardless of the plasma concentration. This usually occurs because the elimination enzymes become saturated. * **Alcohol (Ethanol):** Follows zero-order kinetics at almost all social and clinical concentrations. * **Phenytoin & Theophylline:** These follow "Capacity-limited" or **Michaelis-Menten kinetics**. At low doses, they follow first-order, but at therapeutic or high doses, the metabolic enzymes saturate, shifting them to zero-order kinetics. This makes their plasma levels rise disproportionately with small dose increases, leading to toxicity. **3. High-Yield Clinical Pearls for NEET-PG:** To remember drugs following Zero-order kinetics, use the mnemonic **"WATT P"**: * **W**arfarin (at very high doses) * **A**lcohol / **A**spirin (at high doses) * **T**heophylline * **T**olbutamide * **P**henytoin **Key Distinction:** * **First-order:** Half-life ($t_{1/2}$) is **constant**. * **Zero-order:** Half-life ($t_{1/2}$) is **variable** (increases with dose/concentration). This is why drugs like Phenytoin require therapeutic drug monitoring (TDM).

Practice by Chapter

Absorption and Bioavailability

Practice Questions

Drug Distribution and Protein Binding

Practice Questions

Biotransformation and Metabolism Pathways

Practice Questions

Renal and Non-renal Excretion

Practice Questions

Compartment Models

Practice Questions

Dose-Response Relationships

Practice Questions

Drug Efficacy and Potency

Practice Questions

Drug Tolerance and Tachyphylaxis

Practice Questions

Population Pharmacokinetics

Practice Questions

Pharmacokinetic Variability

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free